A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/1997
11/13/1997	WO1997024116A3 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
11/13/1997	CA2253919A1 Reparation and prevention of fibrotic lesions
11/13/1997	CA2253322A1 Gene expression in monocytes and macrophages
11/13/1997	CA2251129A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides
11/13/1997	CA2204067A1 Chlorhexidine glucomate-containing, stabilized aqueous pharmaceutical preparations
11/12/1997	EP0806422A2 Anti-cataract agent
11/12/1997	EP0806206A1 Aqueous compositions containing ciprofloxacine, and related use and process
11/12/1997	EP0805859A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
11/12/1997	EP0805858A2 Inhibition of neovascularization using vegf-specific oligonucleotides
11/12/1997	CN1164858A Trophic factors for central nervous system regeneration
11/12/1997	CN1164400A Method for preparation of drug for curing cataract of livestock
11/12/1997	CN1164392A Method for preparing compound tobramycin suspension for eye
11/12/1997	CN1036396C Process for preparing (E)-3-£2-n-butyl-1-{(4-carboxyl-phenyl)methyl}-1H-imidazol-5-yl}-2-(2-thienyl) methyl-2-acrylic methylsulfonate
11/12/1997	CN1036393C 7-(2-aminoethyl)-benzothiazolones
11/12/1997	CN1036389C Phenylacetyl deriv. of 4-amino-2,6-dimethyl phenylsulfonyl-nitro-methane or preparing process thereof
11/11/1997	US5686622 Thiazolidine derivatives, their preparation and the medicaments containing the same
11/11/1997	US5686586 Polycyclic aromatic derivatives, process for preparing the same and pharmaceutical and cosmetic compositions containing the same
11/11/1997	US5686414 Methods of treating conditions associated with corneal transplantation
11/10/1997	CA2204582A1 Anti-cataract agent
11/06/1997	WO1997041147A1 Novel compounds
11/06/1997	WO1997041103A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
11/06/1997	WO1997040831A1 Therapeutic treatment for vegf related occular diseases
11/06/1997	WO1997032598A3 Vaccines
11/06/1997	CA2253282A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
11/05/1997	EP0804479A1 Method of treating diabetes mellitus using kgf
11/05/1997	EP0804463A1 Neurokinine (tachykinine) antagonists
11/05/1997	EP0804419A1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
11/05/1997	EP0804194A1 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
11/05/1997	EP0804179A2 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity
11/05/1997	EP0544756B1 1,2,5,6-tetrahydro-1-methylpyridines, their preparation and use
11/04/1997	US5684015 Angiotensin antagonist as hypotensive agents and cardiovascular disorders
10/1997
10/30/1997	WO1997040045A1 Heterocyclic compounds and their preparation and use
10/30/1997	WO1997040044A1 Heterocyclic compounds
10/30/1997	WO1997040043A1 Heterocyclic compounds
10/30/1997	WO1997040031A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
10/30/1997	WO1997040016A1 Heterocyclic compounds
10/30/1997	WO1997040012A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
10/30/1997	WO1997039753A1 Heterocyclic compounds
10/30/1997	WO1997039751A1 Compositions comprising a nitrone compound for use in treating ocular inflammation
10/30/1997	CA2252573A1 Heterocyclic compounds
10/30/1997	CA2252563A1 Heterocyclic compounds and their preparation and use
10/30/1997	CA2252527A1 Heterocyclic compounds
10/30/1997	CA2252494A1 Compositions comprising a nitrone compound for use in treating ocular inflammation
10/30/1997	CA2250873A1 Heterocyclic compounds
10/30/1997	CA2250472A1 Heterocyclic compounds
10/29/1997	EP0802983A2 Expression of urokinase plasminogen activator inhibitors
10/28/1997	US5681848 Vision disorders
10/28/1997	US5681577 Multiple action cold/sinus preparations
10/23/1997	WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997	WO1997038674A1 Ophthalmic compound with extended dwell time on the eye
10/23/1997	WO1997038665A2 Inhibitors of farnesyl-protein transferase
10/23/1997	WO1997034586A3 Device and method for treating ophthalmic diseases
10/23/1997	CA2249601A1 Inhibitors of farnesyl-protein transferase
10/22/1997	EP0801948A1 Ophthalmic composition having prolonged residence time in the eye
10/22/1997	EP0697858B1 Nasal drug delivery composition containing nicotine
10/22/1997	EP0576426B1 Ryegrass pollen allergen
10/21/1997	US5679782 Inhibit receptor binding activity of urokinase-type plasminogen activator
10/21/1997	US5679713 Pharmaceutical composition containing carbachol and other cholinergic substances
10/21/1997	US5679711 Hydroxyl ions as novel therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents
10/21/1997	US5679700 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
10/21/1997	US5679680 α-substituted hydrazides having calpain inhibitory activity
10/21/1997	US5679348 Applying a local therapeutic or prophylactic vaccine for the eye comprising one or more recombinant hsv-1 glycoproteins
10/21/1997	US5679339 Method of using IL-11 for treating spondyloarthropies
10/16/1997	WO1997038084A2 Polynucleotides derived from a pbmc cdna library encoding secreted proteins
10/16/1997	WO1997038007A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997	WO1997038004A1 Gene family associated with neurosensory defects
10/16/1997	WO1997038002A1 Extracellular/epidermal growth factor-like protein
10/16/1997	WO1997037974A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997	WO1997037973A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997	WO1997037688A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
10/16/1997	WO1997037666A1 Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents
10/16/1997	WO1997037655A1 αvβ3 ANTAGONISTS
10/16/1997	WO1997037650A1 Remedies for retinal diseases
10/16/1997	WO1997037542A1 Gene therapy for proliferative vitreoretinopathy
10/16/1997	WO1997030178A3 Diagnosing trinucleotide repeat diseases and genes involved therein
10/16/1997	CA2650637A1 Pharmaceutical composition containing angiotensin ii antagonist
10/16/1997	CA2251603A1 Gene family associated with neurosensory defects
10/16/1997	CA2251078A1 Gene therapy for proliferative vitreoretinopathy
10/16/1997	CA2251017A1 .alpha.v.beta.3 antagonists
10/16/1997	CA2250860A1 Polynucleotides encoding secreted proteins
10/16/1997	CA2249213A1 Extracellular/epidermal growth factor-like protein
10/16/1997	CA2248082A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997	CA2248070A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997	CA2247964A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/15/1997	EP0801132A2 Staphylococcal FtsH protein
10/15/1997	EP0800517A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
10/15/1997	EP0800510A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases
10/15/1997	EP0800504A1 Tricyclic retinoids, methods for their production and use
10/15/1997	EP0800503A1 Novel trienoic retinoid compounds and methods
10/15/1997	CN1162267A Methods and compositions for specific coagulation of vasculature
10/14/1997	US5677451 Controlling cell differentiation; skin disorders; anticancer agents
10/14/1997	US5677321 Anesthetic premedication
10/09/1997	WO1997037026A1 Novel compounds
10/09/1997	WO1997036906A1 Heterocyclic compounds and their preparation and use
10/09/1997	WO1997036901A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036900A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036898A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036897A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036896A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036892A1 Inhibitors of farnesyl-protein transferase

1 ... 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 ... 531